CVE-2026-68067: fallo crítico en Quanovate Tech Inc. (operating as Mira / Mira…
Mira Hormone Monitor, Mira Android App Weak Authentication
Publicada el · Actualizada el
Aviso por correo cuando entre en el KEV, tenga PoC pública o suba de nota.
28Vexday Risk Score
Sin señal de explotación. Ningún artefacto público de explotación conocido hasta ahora.
ssvc Trackcvss 9.3epss 0.5%
The login endpoint on the Mira cloud API accepts any format-valid string in the password field and returns a live active session token for the account matching the supplied email address. An attacker could use an email address to control cloud accounts and access hormone record information and account settings.
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N
Productos afectados
Quanovate Tech Inc. (operating as Mira / Mira Care) · Mira Android AppQuanovate Tech Inc. (operating as Mira / Mira Care) · Mira FirmwareCVEs relacionadas — Quanovate Tech Inc. (operating as Mira / Mira…
En el mismo producto, de las más peligrosas a las menos.
CVE-2026-67568CRITICALMira Hormone Monitor, Mira Android App Use of Hard-coded CredentialsEPSS 0.4%CVE-2026-66875HIGHMira Hormone Monitor, Mira Android App Missing authentication for critical functionEPSS 0.4%CVE-2026-66340MEDIUMMira Hormone Monitor, Mira Android App Improper restriction of excessive authentication attemptsEPSS 0.4%CVE-2026-66832MEDIUMMira Hormone Monitor, Mira Android App Use of GET request method with sensitive query stringsEPSS 0.4%CVE-2026-66098HIGHMira Hormone Monitor, Mira Android App Missing authentication for critical functionEPSS 0.3%CVE-2026-64934MEDIUMMira Hormone Monitor, Mira Android App Reliance on untrusted inputs in a security decisionEPSS 0.3%